June 13, 2024
Idorsia shareholders voted in favor of all proposals by the Board
At today’s Annual General Meeting (AGM) of Idorsia Ltd (SIX: IDIA) held in Basel, Switzerland, shareholders voted in favor of…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Europe
June 12, 2024
Clasado in deal with Prochin for Bimuno GOS prebiotic in China
Clasado Biosciences has signed a new exclusive distribution agreement with Shanghai Prochin, a division of health ingredient specialist, Alliance Nutrition Group, which will see galactooligosaccharide ingredient Bimuno GOS made available to health and nutrition formulators in China, marking another exciting step in the commercial growth of Bimuno GOS.
June 12, 2024
Asgard Therapeutics selects Exothera for clinical trials of its viral vector-based immunotherapy candidate
Asgard Therapeutics, a privately held biotech company pioneering in vivo direct cell reprogramming for cancer immunotherapy, today announced it selected…
June 11, 2024
Banook Group deploys growth strategy with acquisitions of Keosys and B.Research
Banook Group, global provider of technology and services for clinical trial operators, today announces two strategic acquisitions that enhance its…
June 11, 2024
Benchling Builds Digital Data Foundation Powering Sanofi AI-Driven R&D
Benchling, the R&D Cloud powering the biotech industry, today announced that global pharmaceutical company Sanofi is using Benchling across more than 1,500…
June 11, 2024
NMD Pharma starts phase 2b trial of NMD670 in generalized myasthenia gravis patients
NMD Pharma A/S, a clinical-stage biotech company dedicated to developing novel and improved treatments for patients living with neuromuscular diseases,…
June 7, 2024
CordenPharma, Certest team up to add ionizable lipids to CordenPharma’s complex LNP formulation services
CordenPharma and Certest are partnering up to add ionizable lipids to CordenPharma’s complex LNP formulation services
June 7, 2024
Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)
Initial data from the ongoing Phase 2 trial showed a 12-month overall survival rate of 69% and a median overall…
March 1, 2024
Prange Group’s Adragos Pharma acquires Fresenius Kabi production site in Norway
The Prange Group and its affiliate Adragos Pharma have successfully acquired the Fresenius Kabi production site in Halden, Norway, a leading sterile pharmaceutical manufacturing facility. This strategic move signifies a significant step forward for both companies, expanding their global footprint and enhancing their capacity for sterile liquid production.
March 1, 2024
Dupixent shows promise in treating severe asthma
New findings from the VESTIGE trial reveal the effectiveness of Dupixent (dupilumab) in managing uncontrolled moderate-to-severe asthma.